Samsung Biologics brings 1 presentation to BPI 2026 in Boston, and exhibits at Booth 525. Its session covers the development of bispecific and multispecific antibodies. It sets out the challenges these complex molecules pose and strategies for handling them with confidence.
| Organization | BPI 2026 Attendance |
|---|---|
Samsung Biologics Incheon, South Korea | 1 Vice President, Antibody Purification Process Development |
Contract development and manufacturing organization for biologics, from cell line development through large-scale commercial drug substance and drug product. | Booth Exhibiting at Booth 525 Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm Talk Wed Sep 23 1:00pm–1:45pm From Complexity to Confidence: Challenges and Strategies for Bispecific and Multispecific Antibody Development CMC & Manufacturing Strategy |
Instantly find 20 buyers from Samsung Biologics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction